A new study published in the New England Journal of Medicine found that the 13-valent polysaccharide conjugate vaccine (Pfizer s Prevnar 13/PCV13) was effective in protecting seniors from the strains of pneumococcus (a bacterium that causes infections
Yesterday we discussed the remarkable efficacy of routine vaccines against previously dangerous infections, particularly measles, and what happens when parents fail to vaccinate their children.
Medically, it just never made sense. Pfizer s Prevnar-13 pneumonia vaccine works very well in protecting against infection by Streptococcus pneumoniae the most common type of pneumonia, and the leading cause of death for adults 65 and older. (The 13 refers to the number of strains of the bacteria that the vaccine is designed to protect against.)
Here s more good news on the vaccine front. Prevnar the 7-valent pneumococcal conjugate vaccine, meaning it protects against seven different strains of the bug